Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.
Introduced
Jan 16, 2026
Last Action
Jan 16, 2026
Session
RI 2026
Sponsors
10 primary · 0 co
01/16/2026 Introduced, referred to Senate Health and Human Services